Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

BIOSYENT INC V.RX

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Major
Alternate Symbol(s):  BIOYF

Biosyent Inc is a life science company engaged in marketing of pharmaceutical products & manufacturing & marketing of non-chemical bio & health-friendly insecticides. It acquires or license products & commercializes technology to health & public safety.
Price: $9.50 | Change: $-0.20 | %Change: -2.06%
Volume: 6,795 | Day High/Low: 9.75/9.50 | 52 Week High/Low: 12.82/3.15
View modes: 
3 stars

Another day on the Venture....

V.RX closed DOWN 20 cents today at $9.50  with 13.8M shares out and a 52 wk high of $12.82 T.CPH  ( CPHR on Nasadaq) today closed at $17.97 and set a new 52wk high of $18.14 with 25.6M shares...read more
2 stars

Lets Compare...

Sept. 30,2014                Today                 Change V.RX                $10.84                         $9.50                  DOWN  $1,34 T.GUD            $ 6.14                           $6...read more
2 stars

Many months ago...

I expressed my opinion (CEO Included) that RX shareholders may be better served by uplisting. Today RX is at $9.25 Down 25cents. The TSX Venture just hit an all time low of 675.10 points. Cheers!  rate and reply
5 stars

GUD

Price $6.98, analyst target price $6.78, not attractive  rate and reply
1 star

RE:RE:RE:Lets see.....

CORRECTION:       " illiquidity "  rate and reply
2 stars

RE:RE:Lets see.....

Slater1, From a quantative point of view 1000 shares of RX will cost you around $10,000                                                          1000 shares of GUD will cost you just under $7,000...read more
1 star

RE:Lets see.....

CORRECTION: My apology but GUD is not listed on Nasdaq jet , had CPH on my mind> Cheers!  rate and reply
5 stars

RE:Lets see.....

Owning the same number of shares of GUD isn't the same as owning the same number of shares of RX as there is about 63million more shares of GUD outstanding.  So whatever you're pocketing is not some...read more
2 stars

Lets see.....

You can sell your RX shares at $10.00 buy same # of GUD shares for under $7.00 and pocket over $3.00 per share . In turn you become part of a company with $250 M cash listed on the TSX and Nasdaq...read more
5 stars

RE:A Monster In The Making...

GUD has turned into a healthcare fund. Making loans and equity investments in other funds. Not the Paladin Labs of old.  rate and reply
2.5 stars

A Monster In The Making...

If $125 million dollars from the sale of their FDA priority review. If that was not enough GUD is also raising another +100 M from the proceeds of flow through shares. That's $225 Million of Cash...read more
1 star

Lets Compare.....

On Nov 14,2014   V.RX closed at $10.26           Today            V.RX closed at $10.24 On Nov 14,2014   T.GUD closed at $5.96            Today           T.GUD closed at $6.99   Cheers!  rate and reply
2.5 stars

TSX Venture Highs and Lows.....

10/31/2002        914.70 05/07/2007     3,369.79 (all time high) 12/09/2008        686.02 (all time low) 03/07/2011     2,423.78 TODAY                725.02 So where do we go from here?  do we...read more
3 stars

Its time.....

When will management figure it out or are they just in denial!!! The cat is out of the bag and the retail investors are coming to realize that the odds are stacked against them. The Venture closing...read more
1 star

No surprises here folks.....

just another down day on th TSX and TSX Venture. TSX  down 116.65 points  ( -0.78% ) TSX Venture down 14.86 points  ( -1.93% ) Cheers!  rate and reply
5 stars

A Lot Of Companies.....

Are stuck on this Venture not because they thing its a great place to list but because they lack the market cap and or the affordibility to uplist to a more respectable exchange. A company like...read more
3 stars

Todays Headline....

On TMX Money.com :  " US stocks inch higher renewing highs for Dow Jones Industrials and                                           S&P 500 index." Great for US investors but dif story in Canada, TSX...read more
3 stars

Nice Article ...

Link:   http://www.prospectingjournal.com/the-destruction-of-the-canadian-investor-why-the-tsx-venture-is-failing/ Cheers!  rate and reply
3 stars

Kudos to Cipher.....

Cipher Pharmaceuticals changes ticker to CPH on TSX  and also lists on the US Nasdaq beginning today under the ticker CPHR. Shares up 72 cents in Toronto and 0.8088 USD on the Nasdaq.  Nice when...read more
0 stars

New product release...

NEWS RELEASE BIOSYENT PHARMA LAUNCHES NEW PROKTIS-M® SUPPOSITORIES  FOR IMMEDIATE RELEASE                           NOVEMBER 24, 2014   TORONTO, ONTARIO (November 24, 2014) BioSyent Inc. (“BioSyent”...read more